Sepsis Diagnosis and Management in the Lab | Beckman Coulter
Products & Solutions
Back
Products & Solutions
Core Disciplines
Chemistry Immunoassay Hematology Urinalysis Microbiology Blood Banking Clinical Decision Support Protein Chemistry Service
Workflow & Informatics
Advanced Informatics Automation Systems
Disease State Management
Solutions For
Antimicrobial Resistance Advantaged Workflows Pioneering Digital Hematology Neurology Host Response to Infection High Sensitivity Diagnostics Sepsis Diabetes Diagnostics Cardiovascular Disease Drug Monitoring & Detection
Support
Back
Support
Account Support
Create Account Manage Account Settings View All Account Support
Product Support
DxS Service In Vitro Diagnostic Regulation (IVDR) Manage My Technical Documents Search for Technical Documents Safety Data Sheets (SDS/MSDS) Technical Documents Overview Manage My Warranties & Agreements Request Instrument Support View Services Information View All Product Support
Ordering Support
Manage My Orders Track My Invoices View Return/RMA Policy Get Help with Orders View All Ordering Support
Resources
Back
Resources
Product Training
Browse Learning Lab › Learning Lab Login ›
Education & Research
Webinars Posters
Insights
Clinical Studies & Trends Case Studies Publications
Company
Back
Company
People & Culture
Overview Sustainability Meet Our Teams Inclusion & Belonging How We Work Innovation Transparency
Careers
Job Search › Programs & Grants Office Locations
News & Events
Awards & Recognition Newsroom Blog Events Calendar
Home / Solutions / Sepsis Diagnosis and Management in the Lab

Sepsis Diagnosis and Management in the Lab

 



Understanding Sepsis

Sepsis is a life-threatening condition caused by a dysregulated host immune response to infection and affects more than 49 million people worldwide.1
Identifying the root cause of infection and optimizing antibiotic use is essential to ensure a successful outcome, reduce adverse antibiotic effects, and prevent antibiotic resistance.2
A life-threatening syndrome
0
  • A dysregulated immune response to infection
  • Requires immediate treatment
  • Can progress to septic shock and lead to organ dysfunction and death
A global healthcare crisis
0
  • Responsible for more than 11 M global deaths, annually1
  • The leading cause of hospital readmissions3
  • Accounts for more hospitalization costs than any other disease4
A treatable condition
0
  • Early and appropriate administration of antibiotics decreases sepsis mortality
  • Prompt antibiotics administration improves sepsis outcomes

Importance of Early Sepsis Diagnosis and Management

For septic patients, IVD testing is crucial to support effective treatment. Testing can be done using many different biomarkers and systems belonging to different laboratory disciplines.
Use these educational resources to learn more about the tools to help identify sepsis to bring faster treatment to patients.

Spotting Sepsis: Early Detection Saves Lives

Presenters Drs. Shih Hong-Mo Ph.D, Elena A Sukhacheva and Angela Harrison to take a closer look into the latest research, innovative detection methods, and best practices that can aid healthcare professionals in recognizing sepsis at its earliest stages.

Decoding the host response to infection

The sepsis patient pathway is complicated. Understanding the host response can help.

Sepsis can cause devastating patient consequences and drive significant healthcare costs. Timely administration of antibiotics to patients with sepsis decreases the likelihood of death. Supporting better patient outcomes requires a broad and comprehensive approach.

Tackling antimicrobial resistance can help optimize sepsis treatment.

What if you could act faster and avoid deterioration of a septic patient's health? Follow one woman's journey and Beckman Coulter's role in improving antibiotic therapy decisions.

 

Supporting Better Outcomes for All Patients

Timely treatment is the foundation to successful sepsis intervention, so early sepsis diagnosis is critical. Learn more about our commitment to
early sepsis diagnosis and antimicrobial stewardship.

Patient story

Septic Patient Story

What if you could act faster and avoid deterioration of a septic patient’s health? Follow one woman’s journey in this short video and learn about the tools used to identify sepsis to bring faster treatment.

Watch now
Supporting-Better-Outcomes-Webinar

Sepsis Alliance: More to the CBC

Take a deeper dive into the CBC test results with a special focus on the WBC differential. Learn clues pointing to sepsis recognition to provide the right care to the right patient at the right time.

Watch now

Transforming Infection Detection

Explore innovative diagnostic targets, WBC activation, and the power of digital hematology—and how the CBC and AI are transforming our understanding of the host immune response

Read article
micro sepsis numbers infographic

Accurate Diagnosis Decreases Sepsis Burden

Early recognition of antimicrobial resistance presents an opportunity for improved diagnosis.

Download infographic
One of the main concerns on the management of patients with sepsis and septic shock is the augmentation of antimicrobial efficacy, while preventing the emergence of resistant strains during treatment.
Martinez et al.2

 

Explore Our Sepsis Patient Care Solutions



1. Rudd KE, Johnson SC, Agesa KM, et al. Global, regional, and national sepsis incidence and mortality, 1990-2017: analysis for the Global Burden of Disease Study. Lancet. 2020;395(10219):200-211. doi:10.1016/S0140-6736(19)32989-7

2. Martínez ML, Plata-Menchaca EP, Ruiz-Rodríguez JC, Ferrer R. An approach to antibiotic treatment in patients with sepsis. J Thorac Dis. 2020;12(3):1007-1021. doi:10.21037/jtd.2020.01.47

3. Fact Sheets | Sepsis Alliance. 2023. Accessed August 10, 2023. https://www.sepsis.org/education/resources/fact-sheets/

4. Perman SM, Goyal M, Gaieski DF. Initial emergency department diagnosis and management of adult patients with severe sepsis and septic shock. Scand J Trauma Resusc Emerg Med. 2012;20:41. doi:10.1186/1757-7241-20-41

 

Products
Support
Company Newsletter
Beckman Coulter Life Sciences
Stay Connected
Products
Support
Company
Newsletter
Beckman Coulter Life Sciences
Stay Connected

Information addressed to health professionals. The products presented on this site are for professional use only, and, where applicable, comply with the requirements of the IVD Directive 98/79 / EC. Instructions for use must be consulted before using these products.

 

© 2025 Beckman Coulter, Inc. All rights reserved. Beckman Coulter, the stylized logo, and the Beckman Coulter product and service marks mentioned herein are trademarks or registered trademarks of Beckman Coulter, Inc. in the United States and other countries.

U.S. Government Users Restricted Rights - As per GSA ADP Schedule Contract with Beckman Coulter, Inc., the use, duplication or disclosure is restricted as follows: Beckman Coulter hereby authorizes user to copy those documents published on the World Wide Web by Beckman Coulter, for noncommercial use, and only within the user's organization. Except as expressly provided above, nothing contained herein shall be construed as granting any license or right under any Beckman Coulter copyright. Nothing contained herein shall be construed as granting by implication, estoppel or otherwise any license or right under any patent or trademark of Beckman Coulter or any third party.